General MedicationsORALGeneric
REZULIN
TROGLITAZONE
Standard Dose
400MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview REZULIN is listed in Drugs@FDA under application 020720 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient TROGLITAZONE Form and strength TABLET;ORAL - 400MG Sponsor PFIZER PHARMS Submission history Latest submission status date: 1999-06-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview REZULIN is listed in Drugs@FDA under application 020720 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient TROGLITAZONE Form and strength TABLET;ORAL - 400MG Sponsor PFIZER PHARMS Submission history Latest submission status date: 1999-06-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.